From manual to machine: The shifting landscape of cell therapy automation

This spotlight session examines the transition from manual workflows to automated platforms in cell therapy manufacturing. Participants will gain insights into implementing automation to enhance process control, increase throughput, and support scalable product development across CDMOs, biotech, and pharma manufacturing operations.

Key takeaways:

• Evaluate the benefits and challenges of automating cell therapy production.
• Learn approaches to integrate automation with existing process controls.
• Identify strategies for scaling manufacturing while maintaining quality and reproducibility.
• Explore considerations for partnering with CDMOs and technology providers.
• Understand how automation impacts efficiency, compliance, and product development timelines.